IBC6:XETRA:XETRA-iShares MSCI Australia UCITS (EUR)

ETF | Others |

Last Closing

USD 49.76

Change

+1.16 (+2.39)%

Market Cap

USD 0.41B

Volume

4.64K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.17 (+0.33%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.28%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.13 (+0.47%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.07 (+0.25%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.12 (-0.47%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.07%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.18 (+0.34%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.60 (+0.59%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.00 (+0.52%)

USD 80.38B

ETFs Containing IBC6:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.78% 61% D- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.78% 61% D- 64% D
Trailing 12 Months  
Capital Gain 25.17% 71% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.17% 71% C- 72% C
Trailing 5 Years  
Capital Gain 44.82% 69% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.82% 69% C- 72% C
Average Annual (5 Year Horizon)  
Capital Gain 11.33% 74% C 72% C
Dividend Return 11.33% 73% C 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.36% 41% F 51% F
Risk Adjusted Return 78.91% 76% C+ 79% B-
Market Capitalization 0.41B 61% D- 54% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.